Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q4 2024 value amounting to $2.5 million.

  • Connect Biopharma Holdings' Treasury Shares changed N/A to $180000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $180000.0, marking a year-over-year change of. This contributed to the annual value of $180000.0 for FY2024, which is 0.0% changed from last year.
  • Per Connect Biopharma Holdings' latest filing, its Treasury Shares stood at $180000.0 for Q3 2025.
  • Connect Biopharma Holdings' 5-year Treasury Shares high stood at $2.5 million for Q4 2024, and its period low was $2.4 million during Q4 2023.
  • Its 3-year average for Treasury Shares is $79857.1, with a median of $180000.0 in 2023.
  • Per our database at Business Quant, Connect Biopharma Holdings' Treasury Shares plummeted by 1180.12% in 2024 and then soared by 20000.0% in 2025.
  • Connect Biopharma Holdings' Treasury Shares (Quarter) stood at $180000.0 in 2023, then changed by 0.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025.
  • Its Treasury Shares stands at $180000.0 for Q3 2025, versus $180000.0 for Q2 2025 and $180000.0 for Q1 2025.